Your browser doesn't support javascript.
loading
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients.
Qi, Yu; Xia, Yu; Lin, Zhiyuan; Qu, Yang; Qi, Yangyang; Chen, Yifan; Zhou, Quan; Zeng, Han; Wang, Jiajun; Chang, Yuan; Bai, Qi; Wang, Yiwei; Zhu, Yu; Xu, Le; Chen, Lingli; Kong, Yunyi; Zhang, Weijuan; Dai, Bo; Liu, Li; Guo, Jianming; Xu, Jiejie.
Afiliação
  • Qi Y; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Xia Y; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Lin Z; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Qu Y; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Qi Y; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Chen Y; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Zhou Q; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
  • Zeng H; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
  • Wang J; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Chang Y; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Bai Q; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Wang Y; Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhu Y; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Xu L; Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chen L; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Kong Y; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhang W; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Dai B; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Liu L; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. liu.li@zs-hospital.sh.cn.
  • Guo J; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. guo.jianming@zs-hospital.sh.cn.
  • Xu J; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China. jjxufdu@fudan.edu.cn.
Cancer Immunol Immunother ; 69(8): 1565-1576, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32306075
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apirase / Carcinoma de Células Renais / Linfócitos do Interstício Tumoral / Linfócitos T CD8-Positivos / Evasão da Resposta Imune / Microambiente Tumoral / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apirase / Carcinoma de Células Renais / Linfócitos do Interstício Tumoral / Linfócitos T CD8-Positivos / Evasão da Resposta Imune / Microambiente Tumoral / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha